All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel 
.
| Security |
Imputed
Share Price |
Prev
Shares |
Current
Shares |
Change
(Percent) |
Prev Value
(USD x1000) |
Current Value
(USD x1000) |
Change
(Percent) |
|---|
| TNGX / Tango Therapeutics, Inc.
|
|
|
|
|
|
|
|
| STRO / Sutro Biopharma, Inc.
|
|
|
|
|
|
|
|
| HLVX / HilleVax, Inc.
|
|
|
|
|
|
|
|
| LPTX / Cypherpunk Technologies Inc.
|
|
|
|
|
|
|
|
| RYTM / Rhythm Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| PRME / Prime Medicine, Inc.
|
|
|
|
|
|
|
|
| PVLA / Palvella Therapeutics, Inc.
|
|
|
|
|
|
|
|
| LYRA / Lyra Therapeutics, Inc.
|
|
|
|
|
|
|
|
| IMTX / Immatics N.V.
|
|
|
|
|
|
|
|
| GOSS / Gossamer Bio, Inc.
|
|
|
|
|
|
|
|
| ARTV / Artiva Biotherapeutics, Inc.
|
|
|
|
|
|
|
|
| SEPN / Septerna, Inc.
|
|
|
|
|
|
|
|
| ABVX / ABIVAX Société Anonyme - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| SLRN / Acelyrin, Inc.
|
|
|
|
|
|
|
|
| OKUR / OnKure Therapeutics, Inc.
|
|
|
|
|
|
|
|
| CRIS / Curis, Inc.
|
|
|
|
|
|
|
|
| INZY / Inozyme Pharma, Inc.
|
|
|
|
|
|
|
|
| ACRS / Aclaris Therapeutics, Inc.
|
|
|
|
|
|
|
|
| CLYM / Climb Bio, Inc.
|
|
|
|
|
|
|
|
| ALVR / AlloVir, Inc.
|
|
|
|
|
|
|
|
| JSPR / Jasper Therapeutics, Inc.
|
|
|
|
|
|
|
|
| DAWN / Day One Biopharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| JANX / Janux Therapeutics, Inc.
|
|
|
|
|
|
|
|
| MLYS / Mineralys Therapeutics, Inc.
|
|
|
|
|
|
|
|
| VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| BOLT / Bolt Biotherapeutics, Inc.
|
|
|
|
|
|
|
|
| KRON / Kronos Bio, Inc.
|
|
|
|
|
|
|
|
| VTVT / vTv Therapeutics Inc.
|
|
|
|
|
|
|
|
| SRZN / Surrozen, Inc.
|
|
|
|
|
|
|
|
| TERN / Terns Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| UPB / Upstream Bio, Inc.
|
|
|
|
|
|
|
|
| NUVB.WS / Panacea Acquisition Corp. - Equity Warrant
|
|
|
|
|
|
|
|
| LENZ / LENZ Therapeutics, Inc.
|
|
|
|
|
|
|
|
| NGNE / Neurogene Inc.
|
|
|
|
|
|
|
|
| CTNM / Contineum Therapeutics, Inc.
|
|
|
|
|
|
|
|
| ZYME / Zymeworks Inc.
|
|
|
|
|
|
|
|
| SRZNW / Surrozen, Inc. - Equity Warrant
|
|
|
|
|
|
|
|
| ACLX / Arcellx, Inc.
|
|
|
|
|
|
|
|
| AVDL / Avadel Pharmaceuticals plc
|
|
|
|
|
|
|
|
| CRGX / CARGO Therapeutics, Inc.
|
|
|
|
|
|
|
|
| SRRK / Scholar Rock Holding Corporation
|
|
|
|
|
|
|
|
| ALLK / Allakos Inc.
|
|
|
|
|
|
|
|
| ALMS / Alumis Inc.
|
|
|
|
|
|
|
|
| NKTX / Nkarta, Inc.
|
|
|
|
|
|
|
|
| KLRS / Kalaris Therapeutics, Inc.
|
|
|
|
|
|
|
|
